WellSpring Appoints President

David Mayers has been appointed president of WellSpring Pharma Services and joins the senior leadership team. Mr. Mayers is responsible for all activities associated with the Pharma Services business unit, overseeing plant operations, business development and quality and regulatory affairs.
 
Mr. Mayers has 25 years of pharmaceutical manufacturing experience having held leadership positions in manufacturing, quality, R&D, supply chain, operations, project management and strategy. Most recently, he served as vice president manufacturing operations at Purdue Pharma, where he oversaw the expansion of the facility, implemented a Lean environment and facilitated a corporate QMS supporting global regulatory readiness of the Canadian facility, carving out a significant export and third party manufacturing presence.  
 
“We are excited with the addition of David to the WellSpring Pharma Services team,” said Wendy Shusko, president of WellSpring Pharmaceutical Corp. The increasing complexity of the pharmaceutical environment, coupled with our desire to ensure continued growth and the appropriate positioning of WellSpring Pharma Services has necessitated recent decisions with this senior level role. David will provide the strategic and operational leadership to ensure the transformation and growth strategy of the Canadian operations, including creating a continuous improvement (“CI”) culture and optimizing organizational capability; allowing the organization to maximize growth opportunities and overall profitability.”